Effects of l-amphetamine sulfate on cognitive function in multiple sclerosis patients View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2008-05-16

AUTHORS

R. H. B. Benedict, F. Munschauer, P. Zarevics, D. Erlanger, V. Rowe, T. Feaster, R. L. Carpenter

ABSTRACT

We evaluated the effects of the levo (l) enantiomer of amphetamine sulfate on cognitive function in multiple sclerosis (MS) patients. Using a counterbalanced within-subjects design, 19 MS patients received four single-dose administrations of placebo, 15mg, 30mg, or 45 mg of l-amphetamine. Neuropsychological tests measuring processing speed and memory served as the primary outcomes. Performance on tests of processing speed were improved following the 45 mg condition and the largest effects were observed on the Symbol Digit Modalities Test, which measures visual processing speed and working memory. While episodic memory test effects were in the expected direction, the findings were not statistically significant. These preliminary findings show promise for the use of l-amphetamine for the symptomatic treatment of slowed mental processing in MS. Further placebo-controlled trials are needed to confirm these findings. More... »

PAGES

848

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00415-008-0760-7

DOI

http://dx.doi.org/10.1007/s00415-008-0760-7

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1036320852

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/18481035


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1109", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Neurosciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Amphetamine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Central Nervous System Stimulants", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cognition", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cognition Disorders", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dose-Response Relationship, Drug", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Double-Blind Method", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Administration Schedule", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Memory, Short-Term", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Multiple Sclerosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neuropsychological Tests", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Placebo Effect", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Placebos", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Reaction Time", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Professor of Neurology, Psychiatry and Psychology, Neurology, Suite D6, Buffalo General Hospital, 100 High Street, 14203, Buffalo, NY, USA", 
          "id": "http://www.grid.ac/institutes/grid.413119.f", 
          "name": [
            "Dept. of Neurology, State University of New York, Buffalo School of Medicine and the Jacobs, Neurological Institute, Buffalo, NY, USA", 
            "Professor of Neurology, Psychiatry and Psychology, Neurology, Suite D6, Buffalo General Hospital, 100 High Street, 14203, Buffalo, NY, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Benedict", 
        "givenName": "R. H. B.", 
        "id": "sg:person.07746500064.30", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07746500064.30"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Dept. of Neurology, State University of New York, Buffalo School of Medicine and the Jacobs, Neurological Institute, Buffalo, NY, USA", 
          "id": "http://www.grid.ac/institutes/grid.273335.3", 
          "name": [
            "Dept. of Neurology, State University of New York, Buffalo School of Medicine and the Jacobs, Neurological Institute, Buffalo, NY, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Munschauer", 
        "givenName": "F.", 
        "id": "sg:person.01247704077.43", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01247704077.43"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cognition Pharmaceuticals, New York, NY, USA", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Cognition Pharmaceuticals, New York, NY, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zarevics", 
        "givenName": "P.", 
        "id": "sg:person.014032613374.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014032613374.25"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Albert Einstein, College of Medicine, Bronx, NY, USA", 
          "id": "http://www.grid.ac/institutes/grid.251993.5", 
          "name": [
            "Cognition Pharmaceuticals, New York, NY, USA", 
            "Albert Einstein, College of Medicine, Bronx, NY, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Erlanger", 
        "givenName": "D.", 
        "id": "sg:person.01312330520.08", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01312330520.08"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Midamerica Neuroscience Institute, Lenexa, KS, USA", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Midamerica Neuroscience Institute, Lenexa, KS, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rowe", 
        "givenName": "V.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Midamerica Neuroscience Institute, Lenexa, KS, USA", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Midamerica Neuroscience Institute, Lenexa, KS, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Feaster", 
        "givenName": "T.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Seaside Therapeutics, Inc, Cambridge, MA", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Seaside Therapeutics, Inc, Cambridge, MA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Carpenter", 
        "givenName": "R. L.", 
        "id": "sg:person.01136410075.13", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01136410075.13"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/bf02246156", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010756672", 
          "https://doi.org/10.1007/bf02246156"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/clpt.1994.206", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005676181", 
          "https://doi.org/10.1038/clpt.1994.206"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2008-05-16", 
    "datePublishedReg": "2008-05-16", 
    "description": "We evaluated the effects of the levo (l) enantiomer of amphetamine sulfate on cognitive function in multiple sclerosis (MS) patients. Using a counterbalanced within-subjects design, 19 MS patients received four single-dose administrations of placebo, 15mg, 30mg, or 45 mg of l-amphetamine. Neuropsychological tests measuring processing speed and memory served as the primary outcomes. Performance on tests of processing speed were improved following the 45 mg condition and the largest effects were observed on the Symbol Digit Modalities Test, which measures visual processing speed and working memory. While episodic memory test effects were in the expected direction, the findings were not statistically significant. These preliminary findings show promise for the use of l-amphetamine for the symptomatic treatment of slowed mental processing in MS. Further placebo-controlled trials are needed to confirm these findings.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00415-008-0760-7", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1014525", 
        "issn": [
          "0340-5354", 
          "1432-1459"
        ], 
        "name": "Journal of Neurology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "6", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "255"
      }
    ], 
    "keywords": [
      "processing speed", 
      "cognitive function", 
      "Symbol Digit Modalities Test", 
      "visual processing speed", 
      "mental processing", 
      "neuropsychological tests", 
      "Modalities Test", 
      "subjects design", 
      "multiple sclerosis patients", 
      "expected direction", 
      "test effects", 
      "sclerosis patients", 
      "memory", 
      "preliminary findings", 
      "amphetamine sulfate", 
      "further placebo-controlled trials", 
      "placebo-controlled trial", 
      "single-dose administration", 
      "levo enantiomer", 
      "MS patients", 
      "primary outcome", 
      "symptomatic treatment", 
      "findings", 
      "large effect", 
      "patients", 
      "amphetamine", 
      "processing", 
      "test", 
      "placebo", 
      "speed", 
      "effect", 
      "administration", 
      "trials", 
      "outcomes", 
      "performance", 
      "treatment", 
      "direction", 
      "function", 
      "promise", 
      "sulfate", 
      "use", 
      "design", 
      "MS", 
      "conditions", 
      "enantiomers", 
      "Digit Modalities Test", 
      "episodic memory test effects", 
      "memory test effects"
    ], 
    "name": "Effects of l-amphetamine sulfate on cognitive function in multiple sclerosis patients", 
    "pagination": "848", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1036320852"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00415-008-0760-7"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "18481035"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00415-008-0760-7", 
      "https://app.dimensions.ai/details/publication/pub.1036320852"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2021-12-01T19:21", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20211201/entities/gbq_results/article/article_473.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00415-008-0760-7"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00415-008-0760-7'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00415-008-0760-7'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00415-008-0760-7'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00415-008-0760-7'


 

This table displays all metadata directly associated to this object as RDF triples.

253 TRIPLES      22 PREDICATES      96 URIs      85 LITERALS      26 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00415-008-0760-7 schema:about N07654d13ef1f4b37825cc38dbcc692dc
2 N1e2ae8ab4657406097bad08378dfc2eb
3 N3840d638cafb456b8b34834dc9415876
4 N3949da18e3b34d00a3e4eb8f7dfaecd1
5 N52bf65bae3f14edcbdd435c19e060070
6 N794d69296d1d42e8bea1c30d3c7a8c84
7 N7b4965c9bd7946b99062770813f949b3
8 N8c410fa5a6d04ab0b213d82604ff4ebc
9 N8f9abbe558cc4754a690952ac111a3a8
10 Na64c912e9d0f47cd88b45c6baebc0204
11 Nb2ed3141a49744a3939c41336205e396
12 Nbc071856cdcf498d948473f41cc4d36c
13 Nc1e0f9f8f7be40c08b5fac28352ff9e9
14 Nc51d1ad111be4738b163dd4d26b2e61b
15 Nc8abeaf0d2374043afbfafc7daa6d446
16 Nccfc7e5c42f543c8a920a8206c42db96
17 Nd502fee861e44916ac826ee9d1a47005
18 Ndcc62bfbc65445169d52bceaf993131a
19 Nfb594a43acff4bfdb20d64534f83d99e
20 anzsrc-for:11
21 anzsrc-for:1103
22 anzsrc-for:1109
23 schema:author N876397afd302411c800770e2cfbf35a6
24 schema:citation sg:pub.10.1007/bf02246156
25 sg:pub.10.1038/clpt.1994.206
26 schema:datePublished 2008-05-16
27 schema:datePublishedReg 2008-05-16
28 schema:description We evaluated the effects of the levo (l) enantiomer of amphetamine sulfate on cognitive function in multiple sclerosis (MS) patients. Using a counterbalanced within-subjects design, 19 MS patients received four single-dose administrations of placebo, 15mg, 30mg, or 45 mg of l-amphetamine. Neuropsychological tests measuring processing speed and memory served as the primary outcomes. Performance on tests of processing speed were improved following the 45 mg condition and the largest effects were observed on the Symbol Digit Modalities Test, which measures visual processing speed and working memory. While episodic memory test effects were in the expected direction, the findings were not statistically significant. These preliminary findings show promise for the use of l-amphetamine for the symptomatic treatment of slowed mental processing in MS. Further placebo-controlled trials are needed to confirm these findings.
29 schema:genre article
30 schema:inLanguage en
31 schema:isAccessibleForFree false
32 schema:isPartOf Nca5d106522b145b4a4910a6f8e12ea39
33 Ne0218dab02d34b7c9226b79b9dd3e4ce
34 sg:journal.1014525
35 schema:keywords Digit Modalities Test
36 MS
37 MS patients
38 Modalities Test
39 Symbol Digit Modalities Test
40 administration
41 amphetamine
42 amphetamine sulfate
43 cognitive function
44 conditions
45 design
46 direction
47 effect
48 enantiomers
49 episodic memory test effects
50 expected direction
51 findings
52 function
53 further placebo-controlled trials
54 large effect
55 levo enantiomer
56 memory
57 memory test effects
58 mental processing
59 multiple sclerosis patients
60 neuropsychological tests
61 outcomes
62 patients
63 performance
64 placebo
65 placebo-controlled trial
66 preliminary findings
67 primary outcome
68 processing
69 processing speed
70 promise
71 sclerosis patients
72 single-dose administration
73 speed
74 subjects design
75 sulfate
76 symptomatic treatment
77 test
78 test effects
79 treatment
80 trials
81 use
82 visual processing speed
83 schema:name Effects of l-amphetamine sulfate on cognitive function in multiple sclerosis patients
84 schema:pagination 848
85 schema:productId N5bdde1670e214901904d53e5e6978e18
86 N99501ca1d539451999791042bb835bf1
87 Nf181d8e3c9b047dcbbc0b7e768d40baa
88 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036320852
89 https://doi.org/10.1007/s00415-008-0760-7
90 schema:sdDatePublished 2021-12-01T19:21
91 schema:sdLicense https://scigraph.springernature.com/explorer/license/
92 schema:sdPublisher N567162dc5008488e96a136a31d5f778d
93 schema:url https://doi.org/10.1007/s00415-008-0760-7
94 sgo:license sg:explorer/license/
95 sgo:sdDataset articles
96 rdf:type schema:ScholarlyArticle
97 N07654d13ef1f4b37825cc38dbcc692dc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
98 schema:name Middle Aged
99 rdf:type schema:DefinedTerm
100 N097ec5dd8b7148c29335de5820043b8a rdf:first sg:person.01247704077.43
101 rdf:rest Nd443979ac641414489fddc9af681dac7
102 N10f43a003e3843aa893aacae334eaa74 rdf:first sg:person.01136410075.13
103 rdf:rest rdf:nil
104 N18f5a22f34ac4b7993e24d5f36e7ca49 rdf:first N52de1535e0c54918ae21a074664aa1ec
105 rdf:rest N10f43a003e3843aa893aacae334eaa74
106 N1e2ae8ab4657406097bad08378dfc2eb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Male
108 rdf:type schema:DefinedTerm
109 N3840d638cafb456b8b34834dc9415876 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Drug Administration Schedule
111 rdf:type schema:DefinedTerm
112 N3949da18e3b34d00a3e4eb8f7dfaecd1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Central Nervous System Stimulants
114 rdf:type schema:DefinedTerm
115 N4c74fb3df559461eb5f226fe696b8ae4 rdf:first sg:person.01312330520.08
116 rdf:rest N5e98ca8bc8a74ca1974d5bb7027863b4
117 N52bf65bae3f14edcbdd435c19e060070 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Double-Blind Method
119 rdf:type schema:DefinedTerm
120 N52de1535e0c54918ae21a074664aa1ec schema:affiliation grid-institutes:None
121 schema:familyName Feaster
122 schema:givenName T.
123 rdf:type schema:Person
124 N567162dc5008488e96a136a31d5f778d schema:name Springer Nature - SN SciGraph project
125 rdf:type schema:Organization
126 N5bdde1670e214901904d53e5e6978e18 schema:name dimensions_id
127 schema:value pub.1036320852
128 rdf:type schema:PropertyValue
129 N5e98ca8bc8a74ca1974d5bb7027863b4 rdf:first N6b5ce23b53974a18a2837e0708172d13
130 rdf:rest N18f5a22f34ac4b7993e24d5f36e7ca49
131 N6b5ce23b53974a18a2837e0708172d13 schema:affiliation grid-institutes:None
132 schema:familyName Rowe
133 schema:givenName V.
134 rdf:type schema:Person
135 N794d69296d1d42e8bea1c30d3c7a8c84 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Neuropsychological Tests
137 rdf:type schema:DefinedTerm
138 N7b4965c9bd7946b99062770813f949b3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Placebo Effect
140 rdf:type schema:DefinedTerm
141 N876397afd302411c800770e2cfbf35a6 rdf:first sg:person.07746500064.30
142 rdf:rest N097ec5dd8b7148c29335de5820043b8a
143 N8c410fa5a6d04ab0b213d82604ff4ebc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Adult
145 rdf:type schema:DefinedTerm
146 N8f9abbe558cc4754a690952ac111a3a8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Placebos
148 rdf:type schema:DefinedTerm
149 N99501ca1d539451999791042bb835bf1 schema:name doi
150 schema:value 10.1007/s00415-008-0760-7
151 rdf:type schema:PropertyValue
152 Na64c912e9d0f47cd88b45c6baebc0204 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Dose-Response Relationship, Drug
154 rdf:type schema:DefinedTerm
155 Nb2ed3141a49744a3939c41336205e396 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Humans
157 rdf:type schema:DefinedTerm
158 Nbc071856cdcf498d948473f41cc4d36c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name Female
160 rdf:type schema:DefinedTerm
161 Nc1e0f9f8f7be40c08b5fac28352ff9e9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Memory, Short-Term
163 rdf:type schema:DefinedTerm
164 Nc51d1ad111be4738b163dd4d26b2e61b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
165 schema:name Cognition Disorders
166 rdf:type schema:DefinedTerm
167 Nc8abeaf0d2374043afbfafc7daa6d446 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
168 schema:name Reaction Time
169 rdf:type schema:DefinedTerm
170 Nca5d106522b145b4a4910a6f8e12ea39 schema:volumeNumber 255
171 rdf:type schema:PublicationVolume
172 Nccfc7e5c42f543c8a920a8206c42db96 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
173 schema:name Multiple Sclerosis
174 rdf:type schema:DefinedTerm
175 Nd443979ac641414489fddc9af681dac7 rdf:first sg:person.014032613374.25
176 rdf:rest N4c74fb3df559461eb5f226fe696b8ae4
177 Nd502fee861e44916ac826ee9d1a47005 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
178 schema:name Treatment Outcome
179 rdf:type schema:DefinedTerm
180 Ndcc62bfbc65445169d52bceaf993131a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
181 schema:name Amphetamine
182 rdf:type schema:DefinedTerm
183 Ne0218dab02d34b7c9226b79b9dd3e4ce schema:issueNumber 6
184 rdf:type schema:PublicationIssue
185 Nf181d8e3c9b047dcbbc0b7e768d40baa schema:name pubmed_id
186 schema:value 18481035
187 rdf:type schema:PropertyValue
188 Nfb594a43acff4bfdb20d64534f83d99e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
189 schema:name Cognition
190 rdf:type schema:DefinedTerm
191 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
192 schema:name Medical and Health Sciences
193 rdf:type schema:DefinedTerm
194 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
195 schema:name Clinical Sciences
196 rdf:type schema:DefinedTerm
197 anzsrc-for:1109 schema:inDefinedTermSet anzsrc-for:
198 schema:name Neurosciences
199 rdf:type schema:DefinedTerm
200 sg:journal.1014525 schema:issn 0340-5354
201 1432-1459
202 schema:name Journal of Neurology
203 schema:publisher Springer Nature
204 rdf:type schema:Periodical
205 sg:person.01136410075.13 schema:affiliation grid-institutes:None
206 schema:familyName Carpenter
207 schema:givenName R. L.
208 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01136410075.13
209 rdf:type schema:Person
210 sg:person.01247704077.43 schema:affiliation grid-institutes:grid.273335.3
211 schema:familyName Munschauer
212 schema:givenName F.
213 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01247704077.43
214 rdf:type schema:Person
215 sg:person.01312330520.08 schema:affiliation grid-institutes:grid.251993.5
216 schema:familyName Erlanger
217 schema:givenName D.
218 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01312330520.08
219 rdf:type schema:Person
220 sg:person.014032613374.25 schema:affiliation grid-institutes:None
221 schema:familyName Zarevics
222 schema:givenName P.
223 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014032613374.25
224 rdf:type schema:Person
225 sg:person.07746500064.30 schema:affiliation grid-institutes:grid.413119.f
226 schema:familyName Benedict
227 schema:givenName R. H. B.
228 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07746500064.30
229 rdf:type schema:Person
230 sg:pub.10.1007/bf02246156 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010756672
231 https://doi.org/10.1007/bf02246156
232 rdf:type schema:CreativeWork
233 sg:pub.10.1038/clpt.1994.206 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005676181
234 https://doi.org/10.1038/clpt.1994.206
235 rdf:type schema:CreativeWork
236 grid-institutes:None schema:alternateName Cognition Pharmaceuticals, New York, NY, USA
237 Midamerica Neuroscience Institute, Lenexa, KS, USA
238 Seaside Therapeutics, Inc, Cambridge, MA
239 schema:name Cognition Pharmaceuticals, New York, NY, USA
240 Midamerica Neuroscience Institute, Lenexa, KS, USA
241 Seaside Therapeutics, Inc, Cambridge, MA
242 rdf:type schema:Organization
243 grid-institutes:grid.251993.5 schema:alternateName Albert Einstein, College of Medicine, Bronx, NY, USA
244 schema:name Albert Einstein, College of Medicine, Bronx, NY, USA
245 Cognition Pharmaceuticals, New York, NY, USA
246 rdf:type schema:Organization
247 grid-institutes:grid.273335.3 schema:alternateName Dept. of Neurology, State University of New York, Buffalo School of Medicine and the Jacobs, Neurological Institute, Buffalo, NY, USA
248 schema:name Dept. of Neurology, State University of New York, Buffalo School of Medicine and the Jacobs, Neurological Institute, Buffalo, NY, USA
249 rdf:type schema:Organization
250 grid-institutes:grid.413119.f schema:alternateName Professor of Neurology, Psychiatry and Psychology, Neurology, Suite D6, Buffalo General Hospital, 100 High Street, 14203, Buffalo, NY, USA
251 schema:name Dept. of Neurology, State University of New York, Buffalo School of Medicine and the Jacobs, Neurological Institute, Buffalo, NY, USA
252 Professor of Neurology, Psychiatry and Psychology, Neurology, Suite D6, Buffalo General Hospital, 100 High Street, 14203, Buffalo, NY, USA
253 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...